D-Index & Metrics Best Publications
Genetics
Denmark
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Genetics D-index 77 Citations 20,930 314 World Ranking 1152 National Ranking 10

Research.com Recognitions

Awards & Achievements

2023 - Research.com Genetics in Denmark Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • DNA

Finn Cilius Nielsen spends much of his time researching Genetics, Cell biology, Internal medicine, Molecular biology and Single-nucleotide polymorphism. The study incorporates disciplines such as 5-HT5A receptor, Receptor, Biochemistry, Insulin-like growth factor 2 and Fusion protein in addition to Cell biology. His Internal medicine research includes elements of Endocrinology, Real-time polymerase chain reaction and Oncology.

His Molecular biology study combines topics from a wide range of disciplines, such as Growth factor, Messenger RNA, Gene expression and Cathepsin G. His Messenger RNA research incorporates elements of RNA and Protein biosynthesis. Finn Cilius Nielsen has included themes like Genome and Allele, Haplotype in his Single-nucleotide polymorphism study.

His most cited work include:

  • MicroRNA-10a Binds the 5′UTR of Ribosomal Protein mRNAs and Enhances Their Translation (1023 citations)
  • Ancient human genome sequence of an extinct Palaeo-Eskimo (581 citations)
  • A Family of Insulin-Like Growth Factor II mRNA-Binding Proteins Represses Translation in Late Development (520 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Genetics, Molecular biology, Gene and Cell biology. The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology, Oncology and Genotype. His Oncology research incorporates themes from Breast cancer and Ovarian cancer.

His Molecular biology research focuses on Messenger RNA and how it connects with RNA, Protein biosynthesis and Ribonucleoprotein. His study on Cell biology is mostly dedicated to connecting different topics, such as Cell growth. In Gene expression, he works on issues like Pathology, which are connected to microRNA.

He most often published in these fields:

  • Internal medicine (26.11%)
  • Genetics (24.63%)
  • Molecular biology (17.80%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (26.11%)
  • Oncology (12.76%)
  • Gene (16.91%)

In recent papers he was focusing on the following fields of study:

Finn Cilius Nielsen mostly deals with Internal medicine, Oncology, Gene, Breast cancer and Genetics. His biological study spans a wide range of topics, including Transcriptome, Biopsy, Hazard ratio, Prospective cohort study and Single-nucleotide polymorphism. His research investigates the connection between Gene and topics such as Cancer research that intersect with problems in microRNA, Homologous recombination, Normal oral mucosa, Plasma samples and Real-time polymerase chain reaction.

Finn Cilius Nielsen interconnects Tumor heterogeneity, Mutation, FANCM, Prostate cancer and Risk factor in the investigation of issues within Breast cancer. His work on Genome-wide association study, Genotyping, Genetic testing and DNA repair as part of general Genetics research is frequently linked to Dicentric chromosome, thereby connecting diverse disciplines of science. Finn Cilius Nielsen works mostly in the field of Genotyping, limiting it down to topics relating to Medical genetics and, in certain cases, Germline mutation, Mutation and Gene mutation, as a part of the same area of interest.

Between 2017 and 2021, his most popular works were:

  • Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations (100 citations)
  • Shared heritability and functional enrichment across six solid cancers (41 citations)
  • High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer. (23 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • DNA

His primary scientific interests are in Internal medicine, Oncology, Breast cancer, Gene and Cancer research. His Oncology research includes themes of Exome sequencing, Confidence interval, Biopsy, Colorectal cancer and Genomic Profile. His Breast cancer research is multidisciplinary, incorporating perspectives in Transcriptome, Prostate cancer and Risk factor.

His Gene study frequently links to related topics such as Computational biology. Finn Cilius Nielsen combines subjects such as Real-time polymerase chain reaction, Biomarker, microRNA, Formalin fixed paraffin embedded and Cancer biomarkers with his study of Cancer research. His Cancer research is included under the broader classification of Genetics.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

MicroRNA-10a Binds the 5′UTR of Ribosomal Protein mRNAs and Enhances Their Translation

Ulf Andersson Ørom;Finn Cilius Nielsen;Anders H. Lund.
Molecular Cell (2008)

1637 Citations

Ancient human genome sequence of an extinct Palaeo-Eskimo

Morten Rasmussen;Yingrui Li;Stinus Lindgreen;Jakob Skou Pedersen.
Nature (2010)

871 Citations

A Family of Insulin-Like Growth Factor II mRNA-Binding Proteins Represses Translation in Late Development

Jacob Nielsen;Jan Christiansen;Jens Lykke-Andersen;Anders H. Johnsen.
Molecular and Cellular Biology (1999)

790 Citations

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek.
Cancer Epidemiology, Biomarkers & Prevention (2012)

616 Citations

p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.

N R Christoffersen;R Shalgi;L B Frankel;E Leucci.
Cell Death & Differentiation (2010)

408 Citations

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

Antonis C. Antoniou;Xianshu Wang;Zachary S. Fredericksen;Lesley McGuffog.
Nature Genetics (2010)

394 Citations

RNA‐binding IMPs promote cell adhesion and invadopodia formation

Jonas Vikesaa;Thomas V O Hansen;Lars Jønson;Rehannah Borup.
The EMBO Journal (2006)

393 Citations

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

Adam P. Gregory;Calliope A. Dendrou;Kathrine E. Attfield;Aiden Haghikia;Aiden Haghikia.
Nature (2012)

383 Citations

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Fergus J. Couch;Xianshu Wang;Lesley McGuffog;Andrew Lee.
PLOS Genetics (2013)

352 Citations

Ascertainment Biases in SNP Chips Affect Measures of Population Divergence

Anders Albrechtsen;Finn Cilius Nielsen;Rasmus Nielsen.
Molecular Biology and Evolution (2010)

351 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Finn Cilius Nielsen

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 107

Douglas F. Easton

Douglas F. Easton

University of Trieste

Publications: 93

Eske Willerslev

Eske Willerslev

University of Copenhagen

Publications: 86

Esther M. John

Esther M. John

Stanford University

Publications: 76

Roger L. Milne

Roger L. Milne

Cancer Council Victoria

Publications: 72

Georgia Chenevix-Trench

Georgia Chenevix-Trench

QIMR Berghofer Medical Research Institute

Publications: 72

Melissa C. Southey

Melissa C. Southey

Monash University

Publications: 71

Fergus J. Couch

Fergus J. Couch

Mayo Clinic

Publications: 71

Paul D.P. Pharoah

Paul D.P. Pharoah

University of Cambridge

Publications: 70

Irene L. Andrulis

Irene L. Andrulis

University of Toronto

Publications: 66

Jenny Chang-Claude

Jenny Chang-Claude

German Cancer Research Center

Publications: 64

Ludovic Orlando

Ludovic Orlando

Paul Sabatier University

Publications: 63

Hiltrud Brauch

Hiltrud Brauch

German Cancer Research Center

Publications: 62

Dominique Stoppa-Lyonnet

Dominique Stoppa-Lyonnet

Institute Curie

Publications: 60

Heli Nevanlinna

Heli Nevanlinna

University of Helsinki

Publications: 58

Anna Jakubowska

Anna Jakubowska

Pomeranian Medical University

Publications: 57

Trending Scientists

Jeanne Ferrante

Jeanne Ferrante

University of California, San Diego

Sergio L. Schmukler

Sergio L. Schmukler

World Bank

Jan D. Miller

Jan D. Miller

University of Utah

Andrei K. Yudin

Andrei K. Yudin

University of Toronto

Ronald Gronsky

Ronald Gronsky

University of California, Berkeley

Sang Sub Kim

Sang Sub Kim

Inha University

Jai-Young Lee

Jai-Young Lee

Korea Advanced Institute of Science and Technology

Michael Reth

Michael Reth

University of Freiburg

Dean L. Urban

Dean L. Urban

Duke University

Mary Osborn

Mary Osborn

Max Planck Institute for Biophysical Chemistry

Richard P. Bishop

Richard P. Bishop

International Livestock Research Institute

Thomas Kammer

Thomas Kammer

University of Ulm

Mark A. Whisman

Mark A. Whisman

University of Colorado Boulder

James M. Kauffman

James M. Kauffman

University of Virginia

Guido Reifenberger

Guido Reifenberger

Heinrich Heine University Düsseldorf

Bernardo L. Horta

Bernardo L. Horta

Universidade Federal de Pelotas

Something went wrong. Please try again later.